TargetedOnc articles Copyright (c) 2009 Intellisphere, LLC. All rights reserved. http://www.targetedonc.com/articles TargetedOnc articles TargetedOnc articles en-us Fri, 19 Dec 2014 12:26:49 EST 5 TargetedOnc articles 144 47 http://www.targetedonc.com/articles http://www.targetedonc.com/_media/_core/mainLogo.png <![CDATA[Frontline T-DM1 Fails in Phase III MARIANNE Trial]]>http://www.targetedonc.com/articles/Frontline-T-DM1-Fails-in-Phase-III-MARIANNE-TrialTargetedOnc articlesusFri, 19 Dec 2014 12:07:55 ESTTargetedOnc<![CDATA[Breast Ultrasound Added to Mammography Increases Cancer Detection]]>http://www.targetedonc.com/publications/special-reports/2014/breast-cancer-issue1/Breast-Ultrasound-Added-to-Mammography-Increases-Cancer-DetectionTargetedOnc articlesusWed, 17 Dec 2014 16:31:23 ESTTargetedOnc<![CDATA[Biomarker-Driven Trial of Novel Topo-1 Inhibitor Debuted]]>http://www.targetedonc.com/publications/special-reports/2014/breast-cancer-issue1/Biomarker-Driven-Trial-of-Novel-Topo-1-Inhibitor-DebutedTargetedOnc articlesusWed, 17 Dec 2014 16:27:15 ESTTargetedOnc<![CDATA[Anti-Androgen Not for Male Cancers Alone]]>http://www.targetedonc.com/publications/special-reports/2014/breast-cancer-issue1/Anti-Androgen-Not-for-Male-Cancers-AloneTargetedOnc articlesusWed, 17 Dec 2014 15:58:57 ESTTargetedOnc<![CDATA[Trials Seek Optimal nab-Paclitaxel Regimen for First-Line Use in TNMBC]]>http://www.targetedonc.com/publications/special-reports/2014/breast-cancer-issue1/Trials-Seek-Optimal-nab-Paclitaxel-Regimen-for-First-Line-Use-in-TNMBCTargetedOnc articlesusWed, 17 Dec 2014 15:56:01 ESTTargetedOnc<![CDATA[Obesity as a Risk Factor for Inflammatory Breast Cancer]]>http://www.targetedonc.com/publications/special-reports/2014/breast-cancer-issue1/Obesity-as-a-Risk-Factor-for-Inflammatory-Breast-CancerTargetedOnc articlesusWed, 17 Dec 2014 15:56:01 ESTTargetedOnc<![CDATA[Advances in the Treatment of HER2-Positive Breast Cancer]]>http://www.targetedonc.com/publications/special-reports/2014/breast-cancer-issue1/Advances-in-the-Treatment-of-HER2-Positive-Breast-CancerTargetedOnc articlesusWed, 17 Dec 2014 15:54:59 ESTTargetedOnc<![CDATA[Immune Checkpoint Inhibition in Breast Cancer]]>http://www.targetedonc.com/publications/special-reports/2014/breast-cancer-issue1/Immune-Checkpoint-Inhibition-in-Breast-CancerTargetedOnc articlesusWed, 17 Dec 2014 15:54:20 ESTTargetedOnc<![CDATA[In Practice: Bone Health in Women With Breast Cancer]]>http://www.targetedonc.com/publications/special-reports/2014/bone-health-issue1/In-Practice-Bone-Health-in-Women-With-Breast-CancerTargetedOnc articlesusTue, 16 Dec 2014 17:48:44 ESTTargetedOnc<![CDATA[Lanreotide Approved for Gastroenteropancreatic NETs]]>http://www.targetedonc.com/articles/Lanreotide-Approved-for-Gastroenteropancreatic-NETsTargetedOnc articlesusTue, 16 Dec 2014 16:30:01 ESTTargetedOnc a Targeted Oncology